The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent advances in understanding molecular and synaptic mechanisms of intellectual disabilities (ID) in fragile X syndrome (FXS) and Down syndrome (DS) through animal models have led to targeted controlled trials with pharmacological agents designed to normalize these underlying mechanisms and improve clinical outcomes. However, several human clinical trials have failed to demonstrate efficacy of these targeted treatments to improve surrogate behavioral endpoints. Because the ultimate index of disease modification in these disorders is amelioration of ID, the validation of cognitive measures for tracking treatment response is essential. Here, we present preliminary research to validate the National Institutes of Health Toolbox Cognitive Battery (NIH-TCB) for ID. METHODS: We completed three pilot studies of patients with FXS (total n = 63; mean age 19.3 ± 8.3 years, mean mental age 5.3 ± 1.6 years), DS (n = 47; mean age 16.1 ± 6.2, mean mental age 5.4 ± 2.0), and idiopathic ID (IID; n = 16; mean age 16.1 ± 5.0, mean mental age 6.6 ± 2.3) measuring processing speed, executive function, episodic memory, word/letter reading, receptive vocabulary, and working memory using the web-based NIH-TB-CB, addressing feasibility, test-retest reliability, construct validity, ecological validity, and syndrome differences and profiles. RESULTS: Feasibility was good to excellent (≥80 % of participants with valid scores) for above mental age 4 years for all tests except list sorting (working memory). Test-retest stability was good to excellent, and convergent validity was similar to or better than results obtained from typically developing children in the normal sample for executive function and language measures. Examination of ecological validity revealed moderate to very strong correlations between the NIH-TCB composite and adaptive behavior and full-scale IQ measures. Syndrome/group comparisons demonstrated significant deficits for the FXS and DS groups relative to IID on attention and inhibitory control, a significant reading weakness for FXS, and a receptive vocabulary weakness for DS. CONCLUSIONS: The NIH-TCB has potential for assessing important dimensions of cognition in persons with ID, and several tests may be useful for tracking response to intervention. However, more extensive psychometric studies, evaluation of the NIH-TCB's sensitivity to change, both developmentally and in the context of treatment, and perhaps establishing links to brain function in these populations, are required to determine the true utility of the battery as a set of outcome measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The present study based the task version administered on chronological age, unlike other studies looking at the Toolbox in ID, which have used mental age as estimated through IQ testing.”
From NIH Toolbox Cognition Battery Feasibility in Individuals With Williams Syndrome (2022) · cites this paper as Hessl et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The discrepant performance between these subtests appears consistent with previous findings using the NIHTB-CB in ID (Hessl et al., 2016).”
From NIH Toolbox Cognition Battery Feasibility in Individuals With Williams Syndrome (2022) · cites this paper as Hessl et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“available mouse operant touchscreen paradigms seem to have face validity63,89,101–104 relative to human cognitive touchscreen tasks97, although there is concern that the cognitive profile of Fmr1-KO mice may not emulate the cognitive deficits in the human syndrome63.”
From Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome (2018) · cites this paper as [97]
The cited source says what the claim attributes to it.
In the citing paper
“Efforts to validate the measure in individuals with ID indicate good feasibility in the moderate ID range and a mental age above 5 years (Shields et al., 2020) and convergent validity comparable to the original NIHTB-CB norming study (Hessl et al., 2016).”
From NIH Toolbox Cognition Battery Feasibility in Individuals With Williams Syndrome (2022) · cites this paper as Hessl et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“previous studies examining the NIHTB-CB in ID used mental age to determine which subtest version was administered (Hessl et al., 2016; Shields et al., 2020).”
From NIH Toolbox Cognition Battery Feasibility in Individuals With Williams Syndrome (2022) · cites this paper as Hessl et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“All data for study 3 was entered and managed within the Research Electronic Data Capture (REDCap) [57] system at UC Davis Clinical and Translational Science Center (CTSC).”
MethodPeabody Picture Vocabulary Test
Campbell, J. M., & Dommestrup, A. K. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0649 · Cited by 3,787
TEST REVIEW behavior rating inventory of executive function.
Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2000) · Child Neuropsychology · doi:10.1076/chin.6.3.235.3152 · Cited by 1,925
Behavior Rating Inventory for Executive Function
Gioia, G. A., Isquith, P. K., & Roth, R. M. (2017) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-56782-2_1881-2 · Cited by 1,568 · cited 1×
“The Behavior Rating Inventory of Executive Function (BRIEF) [55] is an 86-item parent or teacher rating to assess executive function and selfregulation in children and teenagers.”
Background(1985) · PubMed · Cited by 1,427
Roizen, N. J., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,331
Cognition assessment using the NIH Toolbox
Weintraub, S., Dikmen, S. S., Heaton, R. K., Tulsky, D. S., Zelazo, P. D., Bauer, P. J., Carlozzi, N. E., Slotkin, J., Blitz, D., Wallner-Allen, K., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182872ded · Cited by 1,287
Self-citationVision assessment using the NIH Toolbox
Varma, R., McKean-Cowdin, R., Vitale, S., Slotkin, J., & Hays, R. D. (2013) · Neurology · doi:10.1212/wnl.0b013e3182876e0a · Cited by 1,178
Leiter International Performance Scale-Revised
Sullivan, S. A. (1998) · Psychology in the Schools · doi:10.1002/(sici)1520-6807(199804)35:2<101::aid-pits1>3.0.co;2-s · Cited by 1,011
Leiter International Performance Scale-Revised
Sullivan, S. A. (1998) · Psychology in the Schools · doi:10.1002/(sici)1520-6807(199804)35:2<195::aid-pits14>3.0.co;2-7 · Cited by 1,007
Research works printed but not linked: 5
- Zelazo PD, Anderson JE, Richler J, Wallner-Allen K, Beaumont JL, Weintraub S. NIH Toolbox Cognitive Function Battery (CFB): measuring executive function and attention. Child Dev. 2013;78(4):16–33.
- Weintraub S, Bauer PJ, Zelazo PD, Wallner-Allen K, Dikmen SS, Heaton RK, et al. I. NIH Toolbox Cognition Battery (CB): introduction and pediatric data. Monogr Soc Res Child Dev. 2013;78(4):1–15. · DOI · Paper page
- Carlozzi N, Tulsky DS, Kail RV, Beaumont JL. NIH Toolbox Cognitive Function Battery (CFB): measuring processing speed. Child Dev. 2013;78(4):88–102.
- Gershon R, Slotkin J, Manly J, Blitz D, Beaumont JL, Schnipke D, et al. NIH Toolbox Cognitive Function Battery (CFB): measuring language (vocabulary comprehension and reading decoding). Child Dev. 2013;78(4):49–69.
- Zelazo PD, Bauer PJ. National Institutes of Health Toolbox—Cognitive Function Battery (NIH Toolbox CFB): validation for children between 3 and 15 years: child development. Monographs of the society for research in child development. 2013;78(4):1–172. · DOI · Paper page
Cited by
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Self-citationDrug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336
Self-citationArbaclofen in fragile X syndrome: results of phase 3 trials
Berry-Kravis, E., Hagerman, R., Visootsak, J., Budimirovic, D., Kaufmann, W. E., Cherubini, M., Zarevics, P., Walton-Bowen, K., Wang, P., Bear, M. F., et al. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9181-6 · Cited by 183
“and the NIH Toolbox cognitive battery [37], and these types of measures have been increasingly incorporated in subsequent trials, including the KiTAP computerized”
MethodSelf-citationUpdated report on tools to measure outcomes of clinical trials in fragile X syndrome
Budimirovic, D. B., Berry-Kravis, E., Erickson, C. A., Hall, S. S., Hessl, D., Reiss, A. L., King, M. K., Abbeduto, L., & Kaufmann, W. E. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9193-x · Cited by 157
“A recently published series of pilot studies from this group using NIH-TCB measures provides preliminary evidence of feasibility, test-retest reliability, convergent validity, and sensitivity to group differences [38].”
BackgroundSelf-citationBerry-Kravis, E. M., Harnett, M. D., Reines, S. A., Reese, M. A., Ethridge, L. E., Outterson, A. H., Michalak, C., Furman, J., & Gurney, M. E. (2021) · Nature Medicine · doi:10.1038/s41591-021-01321-w · Cited by 131
Self-citation
Metadata
- Authors
- Hessl, D., Sansone, S. M., Berry-Kravis, E., Riley, K., Widaman, K. F., Abbeduto, L., Schneider, A., Coleman, J., Oaklander, D., Rhodes, K. C., & Gershon, R. C.
- Affiliations
- University of California Davis Medical Center (US)
- University of Denver (US)
- University of California, Riverside (US)
- Rush University Medical Center (US)
- Northwestern University (US)
- Corresponding author
- Hessl, David
- ORCID
- Venue
- Journal of Neurodevelopmental Disorders
- Published
- 2016-09-06
- Volume
- 8
- Issue
- 1
- Pages
- 35-35
- ISSN
- 1866-1947 (ISSN-L)
- 1866-1955
- PMC
- PMC5012003
- OpenAlex
- W2517687243
- Cited by
- 126
- References
- 79
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 11 · 2023: 18 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 13 · 2018: 8 · 2017: 9 · 2016: 3
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Journal of Neurodevelopmental Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Digital Commons - DU (University of Denver) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD076189, HD079125)
- National Fragile X Foundation
- National Center for Advancing Translational Sciences (TR000002)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Keywords
- intellectual disability, fragile X syndrome, Down syndrome, idiopathic intellectual disability, cognitive assessment, test-retest reliability, construct validity, ecological validity, processing speed, executive function, working memory, episodic memory, receptive vocabulary, reading, adaptive behavior, treatment response monitoring, inhibitory control, attention deficits, reading deficits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. https://app.cochat.ai/papers/10.1186/s11689-016-9167-4
- The paper
- Hessl, D., Sansone, S. M., Berry-Kravis, E., Riley, K., Widaman, K. F., Abbeduto, L., Schneider, A., Coleman, J., Oaklander, D., Rhodes, K. C., & Gershon, R. C. (2016). The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. Journal of Neurodevelopmental Disorders. https://doi.org/10.1186/s11689-016-9167-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.